The stock of Tiziana Life Sciences Ltd (TLSA) has gone up by 17.13% for the week, with a 87.07% rise in the past month and a 39.90% rise in the past quarter. The volatility ratio for the week is 18.75%, and the volatility levels for the past 30 days are 16.15% for TLSA. The simple moving average for the past 20 days is 42.73% for TLSA’s stock, with a 28.49% simple moving average for the past 200 days.
Is It Worth Investing in Tiziana Life Sciences Ltd (NASDAQ: TLSA) Right Now?
Company’s 36-month beta value is 0.51.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TLSA is 120.59M, and currently, short sellers hold a 0.21% ratio of that floaft. The average trading volume of TLSA on April 29, 2024 was 167.50K shares.
TLSA) stock’s latest price update
The stock of Tiziana Life Sciences Ltd (NASDAQ: TLSA) has decreased by -7.25 when compared to last closing price of 0.84.Despite this, the company has seen a gain of 17.13% in its stock price over the last five trading days. Proactive Investors reported 2024-04-25 that Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled new neuroimaging data which shows its investigational drug intranasal foralumab improved White Matter Z-scores in patients with non-secondary progressive Multiple Sclerosis (na-SPMS). White Matter Z-scores are a statistical measure in neuroimaging studies used to assess the integrity or abnormalities of structures in the brain.
Analysts’ Opinion of TLSA
Many brokerage firms have already submitted their reports for TLSA stocks, with B. Riley Securities repeating the rating for TLSA by listing it as a “Buy.” The predicted price for TLSA in the upcoming period, according to B. Riley Securities is $8 based on the research report published on December 22, 2020 of the previous year 2020.
TLSA Trading at 51.72% from the 50-Day Moving Average
After a stumble in the market that brought TLSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.57% of loss for the given period.
Volatility was left at 16.15%, however, over the last 30 days, the volatility rate increased by 18.75%, as shares surge +71.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +45.32% upper at present.
During the last 5 trading sessions, TLSA rose by +17.13%, which changed the moving average for the period of 200-days by +14.59% in comparison to the 20-day moving average, which settled at $0.5629. In addition, Tiziana Life Sciences Ltd saw 39.30% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for TLSA
The total capital return value is set at -0.74.
Based on Tiziana Life Sciences Ltd (TLSA), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -21.82. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -1434.29.
Currently, EBITDA for the company is -15.34 million with net debt to EBITDA at 0.62.
Conclusion
In a nutshell, Tiziana Life Sciences Ltd (TLSA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
